BioMarin Pharmaceutical : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K
IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE ELAINE WANG, derivatively on ...
Source: marketscreener.com
Jacques Bienaim News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jacques Bienaim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jacques Bienaim Today - Breaking & Trending Today
Genentech Veteran Named New BioMarin CEO as Gene Therapy Launch Ramps Up
BioMarin Pharmaceutical CEO Jean-Jacques Bienaimé will retire in December, when he will be succeeded by Genentech CEO Alexander Hardy. The transition comes with BioMarin in the early stages of the commercial launch of Roctavian, the first FDA-approved hemophilia A gene therapy.
Source: medcitynews.com
BioMarin Now Turns To Commercializing Its Gene Therapy, Roctavian
As BioMarin turns to commercialization of Roctavian, we will likely hear more about how warranties could help gene therapies overcome payer reimbursement hurdles.
Source: forbes.com
BioMarin layoffs to save $50M a year; cash will go to pipeline, gene therapy launch prep
BioMarin Pharmaceutical said the layoffs will improve efficiency across the company as it prepares for the potential U.S. launch of Roctavian, a gene therapy for severe hemophilia A. The one-time treatment was approved in Europe in August.
Source: medcitynews.com